Form 8-K - Current report:
SEC Accession No. 0001213900-20-011048
Filing Date
2020-05-05
Accepted
2020-05-05 17:11:03
Documents
1
Period of Report
2020-04-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea121215-8k_actiniumpharma.htm 8-K 26141
  Complete submission text file 0001213900-20-011048.txt   27355
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 20849950
SIC: 2834 Pharmaceutical Preparations